Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pentaerithrityltetranitrat (PETN) Zur Sekundärprophylaxe Der Intrauterinen Wachstumsretardierung

NCT03669185 is registered in ClinicalTrials.gov with Jena University Hospital as lead sponsor.

NCT NCT03669185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03669185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pentaerithrityltetranitrat (PETN) Zur Sekundärprophylaxe Der Intrauterinen Wachstumsretardierung
Lead sponsor
Jena University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
July 26, 2017
Completion date
October 31, 2021
Enrollment
324 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth retardation, intrauterine growth restriction, pregnancy related